Table 1 Experimental series
From: MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury
Treatment | Intervention | |||
---|---|---|---|---|
15 min | 1 h | 24 h | ||
Series 1 | ||||
Group 1 (n=6) | Control | MRI | MRI euthanize | |
Group 2 (n=6) | Glibenclamide | MRI | MRI euthanize | |
Series 2 | ||||
Group 1 (n=8) | Control | Euthanize section spinal cord | ||
Group 2 (n=8) | Control | mBBB score euthanize section spinal cord | ||
Group 3 (n=8) | Glibenclamide | mBBB score euthanize section spinal cord |